I have posted my notes on today's Celgene (CELG) analyst conference call:
Celgene (CELG) Q2 analyst call
The key takeaway was updated 2013 guidance.
I'll also be taking notes on Biogen Idec and Gilead today. I have a Xilinx article in the Seeking Alpha queue that needs some links to be added. I will probably write about Celgene next, then Akamai, Biogen, Gilead, and Intel and Altera updates, if I have time.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment